tiprankstipranks
Company Announcements

Chromocell Therapeutics Merges into Channel Therapeutics

Pick the best stocks and maximize your portfolio:

Chromocell Therapeutics Corp ( (CHRO) ) has provided an announcement.

Chromocell Therapeutics Corporation has merged into its subsidiary, Channel Therapeutics Corporation, transitioning from Delaware to Nevada jurisdiction. This reincorporation means Channel Therapeutics now holds the assets, rights, and obligations of Chromocell and continues to be listed on NYSE American under the symbol ‘CHRO’. The move includes updates to indemnification agreements for directors and officers, reflecting Nevada laws, and may impact stockholder rights.

See more data about CHRO stock on TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App